ONCASPAR

Google image searchProduct monograph

Active ingredient

pegaspargase, 750 UNIT/ML

DIN: 02461900

Dosage form(s): SOLUTION

Route(s) of administration: INTRAMUSCULAR, INTRAVENOUS

Description: 3750 UNITS / 5 ML. SINGLE USE VIAL

Schedule: Prescription / Schedule D

Company: SERVIER CANADA INC

Date: 27-MAY-2019

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
• L01XX — Other antineoplastic agents (ATC, ATC/DDD)
• L01XX24 — PEGASPARGASE (ATC/DDD)

External Links for Oncaspar

Search on Google

• Oncaspar side effects
• Oncaspar dosage
• pegaspargase side effects
• pegaspargase dosage

Servier Canada Inc

Go to Servier website to see drug product details. Sometimes you can find oncaspar photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.